Minnesota SF 3711: Certain activities prohibition by Internet service providers serving Minnesota customers and those under contract to the state or political subdivisions

Bill Text

1.1 A bill for an act​
1.2 relating to public safety; classifying kratom as a Schedule II controlled substance;​
1.3 amending Minnesota Statutes 2024, section 152.02, subdivision 3; repealing​
1.4 Minnesota Statutes 2024, section 152.027, subdivision 7.​
1.5 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:​
1.6 Section 1. Minnesota Statutes 2024, section 152.02, subdivision 3, is amended to read:​
1.7 Subd. 3.Schedule II.(a) Schedule II consists of the substances listed in this subdivision.​
1.8 (b) Unless specifically excepted or unless listed in another schedule, any of the following​
1.9 substances whether produced directly or indirectly by extraction from substances of vegetable​
1.10 origin or independently by means of chemical synthesis, or by a combination of extraction​
1.11 and chemical synthesis:​
1.12 (1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or​
1.13 opiate.​
1.14 (i) Excluding:​
1.15 (A) apomorphine;​
1.16 (B) thebaine-derived butorphanol;​
1.17 (C) dextrophan;​
1.18 (D) nalbuphine;​
1.19 (E) nalmefene;​
1.20 (F) naloxegol;​
1​Section 1.​
26-05964 as introduced​10/29/25 REVISOR KLL/RC​
SENATE​
STATE OF MINNESOTA​
S.F. No. 3711​NINETY-FOURTH SESSION​
(SENATE AUTHORS: MANN, Gustafson, Boldon, Utke and Kupec)​
OFFICIAL STATUS​D-PG​DATE​
Introduction and first reading​6342​02/19/2026​
Referred to Judiciary and Public Safety​
Authors added Gustafson; Boldon​6380​02/23/2026​
Author added Utke​6462​03/02/2026​
Author added Kupec​6918​03/23/2026​

2.1 (G) naloxone;​
2.2 (H) naltrexone; and​
2.3 (I) their respective salts;​
2.4 (ii) but including the following:​
2.5 (A) opium, in all forms and extracts;​
2.6 (B) codeine;​
2.7 (C) dihydroetorphine;​
2.8 (D) ethylmorphine;​
2.9 (E) etorphine hydrochloride;​
2.10 (F) hydrocodone;​
2.11 (G) hydromorphone;​
2.12 (H) metopon;​
2.13 (I) morphine;​
2.14 (J) oxycodone;​
2.15 (K) oxymorphone;​
2.16 (L) thebaine;​
2.17 (M) oripavine;​
2.18 (2) any salt, compound, derivative, or preparation thereof which is chemically equivalent​
2.19 or identical with any of the substances referred to in clause (1), except that these substances​
2.20 shall not include the isoquinoline alkaloids of opium;​
2.21 (3) opium poppy and poppy straw;​
2.22 (4) coca leaves and any salt, cocaine compound, derivative, or preparation of coca leaves​
2.23 (including cocaine and ecgonine and their salts, isomers, derivatives, and salts of isomers​
2.24 and derivatives), and any salt, compound, derivative, or preparation thereof which is​
2.25 chemically equivalent or identical with any of these substances, except that the substances​
2.26 shall not include decocainized coca leaves or extraction of coca leaves, which extractions​
2.27 do not contain cocaine or ecgonine;​
2.28 (5) concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid,​
2.29 or powder form which contains the phenanthrene alkaloids of the opium poppy).​
2​Section 1.​
26-05964 as introduced​10/29/25 REVISOR KLL/RC​

3.1 (c) Any of the following opiates, including their isomers, esters, ethers, salts, and salts​
3.2 of isomers, esters and ethers, unless specifically excepted, or unless listed in another schedule,​
3.3 whenever the existence of such isomers, esters, ethers and salts is possible within the specific​
3.4 chemical designation:​
3.5 (1) alfentanil;​
3.6 (2) alphaprodine;​
3.7 (3) anileridine;​
3.8 (4) bezitramide;​
3.9 (5) bulk dextropropoxyphene (nondosage forms);​
3.10 (6) carfentanil;​
3.11 (7) dihydrocodeine;​
3.12 (8) dihydromorphinone;​
3.13 (9) diphenoxylate;​
3.14 (10) fentanyl;​
3.15 (11) isomethadone;​
3.16 (12) levo-alpha-acetylmethadol (LAAM);​
3.17 (13) levomethorphan;​
3.18 (14) levorphanol;​
3.19 (15) metazocine;​
3.20 (16) methadone;​
3.21 (17) methadone - intermediate, 4-cyano-2-dimethylamino-4, 4-diphenylbutane;​
3.22 (18) moramide - intermediate, 2-methyl-3-morpholino-1, 1-diphenyl-propane-carboxylic​
3.23 acid;​
3.24 (19) pethidine;​
3.25 (20) pethidine - intermediate - a, 4-cyano-1-methyl-4-phenylpiperidine;​
3.26 (21) pethidine - intermediate - b, ethyl-4-phenylpiperidine-4-carboxylate;​
3.27 (22) pethidine - intermediate - c, 1-methyl-4-phenylpiperidine-4-carboxylic acid;​
3.28 (23) phenazocine;​
3​Section 1.​
26-05964 as introduced​10/29/25 REVISOR KLL/RC​

4.1 (24) piminodine;​
4.2 (25) racemethorphan;​
4.3 (26) racemorphan;​
4.4 (27) remifentanil;​
4.5 (28) sufentanil;​
4.6 (29) tapentadol;​
4.7 (30) 4-Anilino-N-phenethylpiperidine;​
4.8 (31) oliceridine;​
4.9 (32) norfentanyl (N-phenyl-N-(piperidin-4-yl) propionamide).​
4.10 (d) Unless specifically excepted or unless listed in another schedule, any material,​
4.11 compound, mixture, or preparation which contains any quantity of the following substances​
4.12 having a stimulant effect on the central nervous system:​
4.13 (1) amphetamine, its salts, optical isomers, and salts of its optical isomers;​
4.14 (2) methamphetamine, its salts, isomers, and salts of its isom